Table 2 Relationship between NUSAP1 expression level in epithelial ovarian cancer and clinicopathological parameters
From: Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
Characteristics | n | Low | High | High positive rate (%) | P-value | ||
|---|---|---|---|---|---|---|---|
(-) | ( +) | (+ +) | (+ + +) | ||||
FIGO stage | |||||||
  I-II | 34 | 5 | 10 | 9 | 10 | 55.88 | 0.006* |
  III-IV | 44 | 2 | 5 | 18 | 19 | 84.09 | |
Tumor grade | |||||||
  1–2 | 43 | 4 | 12 | 13 | 14 | 62.79 | 0.050 |
  3 | 35 | 3 | 3 | 14 | 15 | 82.86 | |
LN metastasis | |||||||
  No | 33 | 4 | 7 | 9 | 13 | 66.67 |  > 0.050 |
  Yes | 18 | 0 | 3 | 8 | 7 | 83.33 | |
  No lymphadenectomy | 27 | 3 | 5 | 10 | 9 | 70.37 | |
Residual tumor size | |||||||
   ≤ 1 cm | 74 | 7 | 14 | 25 | 28 | 71.62 |  > 0.050 |
   > 1 cm | 4 | 0 | 1 | 2 | 1 | 75.00 | |
Pathologic type | |||||||
  High-grade serous | 43 | 4 | 5 | 14 | 20 | 79.07 |  > 0.050 |
  Low-grade serous | 9 | 1 | 3 | 2 | 3 | 55.56 | |
  Mucinous | 8 | 2 | 2 | 2 | 2 | 50.00 | |
  Endometrioid | 12 | 0 | 5 | 4 | 3 | 58.33 | |
  Clear cell | 6 | 0 | 0 | 5 | 1 | 100.00 | |